XPH

1 BTC

=

- USD

State Street SPDR S&P Pharmaceuticals ETF logo

State Street SPDR S&P Pharmaceuticals ETF

XPH🇺🇸
0.00079185
0.51%

As of May 30, 2026 at 09:30 UTC

Chart

About State Street SPDR S&P Pharmaceuticals ETF

Sector
-
Website
-
Headquarters
-
Employees (FY)
-
Listed
2006-06-19
FIGI
BBG000D73SW9

No description available.

Market Statistics

Market Capâ‚¿ 4.15K
24h Volumeâ‚¿ 9.37
24h Change0.51%
7d Change3.06%
1m Change1.27%

Trading Metrics

Trading Volume (BTC)â‚¿ 9.37

How to Buy XPH

1

Create Your Account

Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.

2

Start Your Trade

From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.

3

Buy XPH

Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.

New to Tokenized Assets? Learn more in our Help Center.

Latest News

5 articles
Benzinga favicon
Benzingawww.benzinga.com

Amneal Pharmaceuticals (AMRX) shares rose 3.76% in premarket trading after announcing a definitive agreement to acquire Kashiv BioSciences for $1.1 billion. The acquisition aims to establish Amneal as a fully integrated global biosimilar platform, positioning it to capitalize on a projected $300 billion global biologics loss-of-exclusivity opportunity. The transaction is expected to close in the second half of 2026, subject to shareholder and regulatory approvals.

Related:
Benzinga favicon
Benzingawww.benzinga.com

Prestige Consumer Healthcare announced a definitive agreement to acquire the Breathe Right brand for $1.045 billion. The acquisition will expand Prestige's consumer health portfolio in sleep and breathing categories and includes other brands like Dimetapp. The deal is expected to close in H1 fiscal 2027 and should boost margins and free cash flow. However, the stock shows technical weakness, trading below its moving averages with negative MACD signals.

Related:
Seeking Alpha favicon
Seeking Alphaseekingalpha.com

Numerous drugs under development are projected to come to market later this year and next for Gilead. Read why I rate GILD stock a Buy.

Zacks Investment Research favicon
Zacks Investment Researchwww.zacks.com

Sector ETF report for XPH

Zacks Investment Research favicon
Zacks Investment Researchwww.zacks.com

We have highlighted five ETFs from different zones that have plunged the most so far this year but have a solid Zacks ETF Rank.

1 BTC

=

- USD

Loading market data...